Hierarchical AF2RAVE integrates AlphaFold2 and enhanced sampling for protein conformational exploration, suggesting improved virtual screening outcomes.
Protein function is driven by transitions between metastable conformations, many of which are not conserved across homologues, offering opportunities for selective drug design. Accurately modeling both backbone and side chain metastability, and generating structures suitable for rigid docking in high-throughput virtual screening, is thus desirable yet challenging. Here, we present a hierarchical AF2RAVE pipeline that integrates AlphaFold2 with machine learning-based enhanced sampling to systematically explore the free energy landscape and metastability of protein systems, particularly at both backbone and side chain levels. Applied to the calcium-binding S100 protein family, this approach enables the generation of diverse holo-like conformations, starting from sequence. Retrospective docking and enrichment testing with a new Ca2+-S100B inhibitor data set demonstrates that AF2RAVE-generated structures outperform standard AlphaFold2 and even outperform experimentally resolved X-ray structures in enrichment testing. Our results highlight the potential of AF2RAVE for high-throughput virtual screening and selective inhibitor discovery, particularly for challenging targets such as the Ca2+-S100 family.
No takes yet. Share an insight, caveat, or question.
Gu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: